Harvard Bioscience
Price & Volume
Stats
See more52W Range | $0.28-$2.07 |
Market Cap | $28.1M |
Shares Short | 586,355 |
Financials
See moreRevenue (12 Mos) | $87.3M |
Revenue Growth (YoY) | -6.3% |
Gross Profit (12 Mos) | $49.7M |
Diluted EPS | -$1.21 |
News
See moreYahoo Finance • 2 months ago
Harvard Bioscience targets $22.5M–$24.5M Q4 revenue as backlog reaches two-year high, expanding product rollouts and distribution
Yahoo Finance • 5 months ago
Judge orders Trump administration to restore part of UCLA's suspended funding
Yahoo Finance • 5 months ago
Harvard Bioscience outlines $19M–$21M Q3 revenue target as debt refinancing advances and product adoption accelerates
Yahoo Finance • 5 months ago
Harvard Bioscience Inc (NASDAQ:HBIO) Reports Mixed Q2 2025 Earnings Amid Revenue Miss and Improved Cash Flow
About
CEO | Mr. John Duke |
CFO | Mr. Mark T. Frost |
Address | 84 October Hill Road, Holliston, MA, United States, 01746 |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Full-Time Employees | 330 |
